Globus Medical (GMED)
Globus Medical, Inc. is a healthcare equipment company focused on musculoskeletal care. The company develops and commercializes a broad range of products and services used in spine, orthopedic trauma, and joint reconstruction procedures in the United States and international markets. Its portfolio includes fusion implants, motion-preservation technologies, vertebral compression fracture treatments, biologics, and hip and knee arthroplasty solutions. Globus Medical also provides spinal cord stimulation and neuromonitoring services, supporting surgical and neurological care in operating rooms and other clinical settings.
In addition, the company offers technology platforms for surgical planning, robotic guidance, navigation, and intraoperative imaging, including the Excelsius line and Surgimap software. Globus Medical also distributes human cells, tissues, and cellular and tissue-based products. The business sells through direct and distributor representatives as well as independent sales agents. Incorporated in 2003, Globus Medical is headquartered in Audubon, Pennsylvania, and its common stock trades on the NYSE under the symbol GMED.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-GMED
|
$110.56
|
44.1% Upside
|
Undervalued
|
$100.92
|
31.5% Upside
|
Undervalued
|
Excellent
|
0.0%
|
November 10, 2026
|
19.1x
|
2.1x
|
3.3x
|
10.28 B
|
9.501 B
|
1.1%
|
82.6%
|
11.5
|
141.1%
|
